| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $291.8M | -10.2% |
| Cost of Revenue | $94.5M | -4.0% |
| Gross Profit | $197.3M | -12.9% |
| R&D Expense | $72.6M | -23.8% |
| SG&A Expense | $69.6M | -0.6% |
| Operating Income | -$26.1M | +15.3% |
| Interest Expense | $4.2M | -39.1% |
| Pre-tax Income | -$9.0M | +32.6% |
| Income Tax | $1.5M | -31.9% |
| Net Income | -$10.5M | +32.5% |
| EPS (Basic) | -$0.11 | +35.3% |
| EPS (Diluted) | -$0.11 | +35.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $299.9M | -28.0% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $596K | -72.7% |
| Current Assets | $457.2M | -17.2% |
| Total Assets | $647.2M | -14.0% |
| Current Liabilities | $409.7M | +11.8% |
| Long-term Debt | $144.4M | -40.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.7M | -50.2% |
| Capital Expenditures | $95K | -84.2% |
| Investing Cash Flow | $21.0M | -83.0% |
| Financing Cash Flow | -$105.8M | +40.4% |
| Free Cash Flow | $17.6M | -49.6% |
| Total Liabilities |
| $468.1M |
| -19.6% |
| Stockholders' Equity | $179.1M | +5.2% |